NES/E2 Transdermal Gel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NES/E2 Transdermal Gel, covering 2015-04-17 to 2015-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women [Phase 2]